Israeli Botanical Company Releases Skin Remedies in US

Clinically Proven Plant-Based Treatments for Eczema, Acne & Dandruff, Now Available in the U.S.

Pharmaceutical companies today are making major investments in plant-derived drugs, with the global market expected to hit nearly $40 billion by 2022 and the largest growth coming in the botanical sector, according to a just-released research report.  But Israeli-based Kamedis has beaten them to market with a line of over-the-counter products that use ancient Chinese medicine to heal problem skin – inspired by the CEO, Roni Kramer, who holds a degree in traditional Chinese medicine and Chinese herbology.